Printer Friendly

Browse Antagonists (Biochemistry) topic

Articles

1-20 out of 20 article(s)
Title Author Type Date Words
Serlopitant quells prurigo nodularis in phase 2 study. Jancin, Bruce Dec 1, 2018 825
"THE EFFECTS OF SUSTAINED DELIVERY OF NPY RECEPTOR ANTAGONIST ON CELLS TYPES WITHIN THE INTERVERTEBRAL DISC". Tucci, Michelle A. Apr 1, 2018 341
Investigation of the role of interleukin-1 receptor antagonist VNTR variant on the Behcet's disease. Dursun, Gul; Nursal, Ayse Feyda; Demir, Helin Deniz; Karakus, Nevin; Demir, Osman; Yigit, Serbulent Report Mar 1, 2018 3904
Prolonged Prothrombin Time After Discontinuing Vitamin K Antagonist. Schellings, Mark W.M.; de Maat, Moniek P.M.; de Lathouder, Sacha; Weerkamp, Floor Clinical report Sep 1, 2017 2107
A Naphthalenic Derivative ND-1 Inhibits Thrombus Formation by Interfering the Binding of Fibrinogen to Integrin [alpha]IIb[beta]3. Ding, Xue; Liu, Tong-dan; Xie, Zhou-ling; Zhao, Qi; Cao, Yuan; Liu, Xiao- dong; Wang, Cai-hui; Gamar Report Jan 1, 2017 4428
Comparison of Ramosetron with Palonosetron for Prevention of Postoperative Nausea and Vomiting in Patients Receiving Opioid-Based Intravenous Patient-Controlled Analgesia after Gynecological Laparoscopy. Ahn, Eun Jin; Choi, Geun Joo; Kang, Hyun; Baek, Chong Wha; Jung, Yong Hun; Woo, Young Cheol Report Jan 1, 2017 4171
High-Sensitivity Troponin I in Stable Patients with Atherosclerotic Disease in the TRA 2[degrees]P - TIMI 50 Trial. Eisen, Alon; Bonaca, Marc P.; Jarolim, Petr; Scirica, Benjamin M.; White, Harvey D.; Tendera, Michal Report Jan 1, 2017 5301
Fimasartan Ameliorates Nonalcoholic Fatty Liver Disease through PPAR[delta] Regulation in Hyperlipidemic and Hypertensive Conditions. Lee, Yong-Jik; Jang, Yoo-Na; Han, Yoon-Mi; Kim, Hyun-Min; Jeong, Jong-Min; Seo, Hong Seog Report Jan 1, 2017 7662
AM966, an Antagonist of Lysophosphatidic Acid Receptor 1, Increases Lung Microvascular Endothelial Permeability through Activation of Rho Signaling Pathway and Phosphorylation of VE-Cadherin. Cai, Junting; Wei, Jianxin; Li, Shuang; Suber, Tomeka; Zhao, Jing Report Jan 1, 2017 6496
Sepsis Strengthens Antagonistic Actions of Neostigmine on Rocuronium in a Rat Model of Cecal Ligation and Puncture. Wu, Jin; Jin, Tian; Wang, Hong; Li, Shi-Tong Report Dec 1, 2016 4719
Preparation and characterization of an antibody antagonist that targets the porcine growth hormone receptor. Cui, Huanzhong; Wang, Yanrong; Song, Meng; Zhang, Hui Report Oct 1, 2016 3218
Importance of embryonic antagonists in regulating populations of processionary Thaumetopoeapityocampa (Denis & Schiffermuller, 1775) Schiff in some Algerian cedar forests. Kherroubi, Mounir; Mouhouche, Fazia; Gahdab, Chakali Report Oct 1, 2016 3830
GABAB Receptor Antagonist (CGP 55845) can be Intraperitoneally Supplemented as it does not Affect the Hematological and Serum Biochemical Profile in Adult Female Albino Mice. Report Dec 31, 2015 2508
QSAR Study of flavonoids as platelet-activating factor (PAF) receptor binding antagonists. Abdullah, N.H.; Kiong, L.S.; Noorbatcha, I.A. Report Mar 1, 2014 2774
Which results to believe? Brief article Dec 1, 2012 138
Effect of pre-ovulatory single dose GnRH agonist therapy on IVF outcome in GnRH antagonist cycles; a prospective study. Kaur, Harpreet; Krishna, Deepika; Shetty, Nivedita; Krishnan, Sandhya; Srinivas, M.S.; Rao, Kamini A Report Nov 17, 2012 4413
Merck heart-failure drug misses goals in study. Brief article Jun 15, 2009 152
Novel agent eases overactive bladder symptoms. Wachter, Kerri Jul 15, 2008 611
Fesoterodine's action against overactive bladder symptoms appears dose-related. Wachter, Kerri Jul 15, 2008 622
TNF antagonist safety in rheumatoid arthritis: updated evidence from observational registries. Nasir, Adeel; Greenberg, Jeffrey D. Clinical report Sep 1, 2007 2536

Terms of use | Privacy policy | Copyright © 2021 Farlex, Inc. | Feedback | For webmasters |